David L. DeMets
Impact in
- Ophthalmology top 0.2%
- Retinal Diseases and Treatments
- Statistics and Probability top 0.2%
- Statistical Methods in Clinical Trials
Papers in
-
- Statistical Methods in Clinical Trials 48
-
- Meta-analysis and systematic reviews 29
- Co-authors
- Ronald KleinScot E. MossMatthew D. DavisCurt D. FurbergLawrence M. FriedmanSusan S. EllenbergK. K. Gordon LanThomas R. Fleming
- Journals
- Circulation (11 papers)Clinical Trials (11 papers)Statistics in Medicine (9 papers)Controlled Clinical Trials (8 papers)The American Journal of Medicine (6 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
David L. DeMets
162 papers receiving 13.5k citations
Hit Papers
Peers
Comparison fields: 5 of 191
- Ophthalmology 2.2k
- Statistics and Probability 1.5k
- Cardiology and Cardiovascular Medicine 3.9k
- Statistics, Probability and Uncertainty 1.0k
- Internal Medicine 482
Countries citing papers authored by David L. DeMets
This map shows the geographic impact of David L. DeMets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. DeMets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. DeMets more than expected).
Fields of papers citing papers by David L. DeMets
This network shows the impact of papers produced by David L. DeMets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. DeMets. The network helps show where David L. DeMets may publish in the future.
Co-authors
The 25 scholars most cited alongside David L. DeMets, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 3 | |
| 4 | 2021 | 8 | |
| 5 | Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the Hit paper breakdown → | 2021 | 182 |
| 6 | 2020 | 2 | |
| 7 | 2019 | 5 | |
| 8 | 2019 | 11 | |
| 9 | 2016 | 7 | |
| 10 | Risk of Chronic Obstructive Pulmonary Disease | 2015 | 2 |
| 11 | Management of Patients With Peripheral Artery Disease (Compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations) Hit paper breakdown → | 2013 | 441 |
| 12 | 2013 | 249 | |
| 13 | 2011 | 40 | |
| 14 | 2004 | 17 | |
| 15 | 2001 | 286 | |
| 16 | 1999 | 31 | |
| 17 | Insights from monitoring the CPCRA didanosine/zalcitabine trial | 1995 | 11 |
| 18 | 1995 | 26 | |
| 19 | 1987 | 59 | |
| 20 | 1984 | 27 |
About David L. DeMets
David L. DeMets is a scholar working on Statistics and Probability, Statistics, Probability and Uncertainty, Cardiology and Cardiovascular Medicine, Ophthalmology and Economics and Econometrics, having authored 163 papers that have together received 14.3k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (48 papers), Health Systems, Economic Evaluations, Quality of Life (31 papers), Meta-analysis and systematic reviews (29 papers), Ethics in Clinical Research (20 papers), Heart Failure Treatment and Management (13 papers), Retinal Diseases and Treatments (12 papers), Diabetes Treatment and Management (11 papers) and Retinal Imaging and Analysis (11 papers). The work is most often cited by research in Ophthalmology (2.2k citations), Statistics and Probability (1.5k citations), Cardiology and Cardiovascular Medicine (3.9k citations), Statistics, Probability and Uncertainty (1.0k citations) and Internal Medicine (482 citations). David L. DeMets has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Ronald Klein, Scot E. Moss, Matthew D. Davis, Curt D. Furberg, Lawrence M. Friedman, Susan S. Ellenberg, K. K. Gordon Lan, Thomas R. Fleming, Polly A. Newcomb and Paul P. Carbone. Their work appears in journals such as Circulation, Clinical Trials, Statistics in Medicine, Controlled Clinical Trials and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.